Factor Xa inhibitors
US8377974B2 · kind B2 · utility
0Cited by
18References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 2011 |
| Grant date | Feb 19, 2013 |
| Priority date | — |
| Expiry date | Aug 19, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.